HIGHLY SPECIFIC INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WHICH ARE PARTICULARLY TARGETED AT THE REVERSE-TRANSCRIPTASE

被引：0
|
作者：
DECLERCQ, E
SNOECK, R
机构：
来源：
PATHOLOGIE BIOLOGIE | 1993年 / 41卷 / 03期
关键词：
HIV; ANTIVIRALS; REVERSE TRANSCRIPTASE; RESISTANCE;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：230 / 236
页数：7
相关论文
共 50 条
  • [21] MUTATIONAL ANALYSIS OF THE FINGERS DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    BOYER, PL
    FERRIS, AL
    HUGHES, SH
    JOURNAL OF VIROLOGY, 1992, 66 (12) : 7533 - 7537
  • [22] ACTION OF URACIL ANALOGS ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND ITS REVERSE-TRANSCRIPTASE
    PIRAS, G
    DUTSCHMAN, GE
    IM, GJ
    PAN, BC
    CHU, SH
    CHENG, YC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) : 539 - 541
  • [23] DIMERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - A TARGET FOR CHEMOTHERAPEUTIC INTERVENTION
    RESTLE, T
    MULLER, B
    GOODY, RS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (16) : 8986 - 8988
  • [24] THE INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE BY AVAROL AND AVARONE DERIVATIVES
    LOYA, S
    HIZI, A
    FEBS LETTERS, 1990, 269 (01) : 131 - 134
  • [25] STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE HETERODIMER
    WANG, J
    SMERDON, SJ
    JAGER, J
    KOHLSTAEDT, LA
    RICE, PA
    FRIEDMAN, JM
    STEITZ, TA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) : 7242 - 7246
  • [26] DIARYLSULFONES, A NEW CHEMICAL CLASS OF NONNUCLEOSIDE ANTIVIRAL INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    MCMAHON, JB
    GULAKOWSKI, RJ
    WEISLOW, OS
    SCHULTZ, RJ
    NARAYANAN, VL
    CLANTON, DJ
    PEDEMONTE, R
    WASSMUNDT, FW
    BUCKHEIT, RW
    DECKER, WD
    WHITE, EL
    BADER, JP
    BOYD, MR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (04) : 754 - 760
  • [27] A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR ACTIVE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES RESISTANT TO RELATED INHIBITORS
    GOLDMAN, ME
    OBRIEN, JA
    RUFFING, TL
    SCHLEIF, WA
    SARDANA, VV
    BYRNES, VW
    CONDRA, JH
    HOFFMAN, JM
    EMINI, EA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) : 947 - 949
  • [28] BENZOPHENONE DERIVATIVES - A NOVEL SERIES OF POTENT AND SELECTIVE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    WYATT, PG
    BETHELL, RC
    CAMMACK, N
    CHARON, D
    DODIC, N
    DUMAITRE, B
    EVANS, DN
    GREEN, DVS
    HOPEWELL, PL
    HUMBER, DC
    LAMONT, RB
    ORR, DC
    PLESTED, SJ
    RYAN, DM
    SOLLIS, SL
    STORER, R
    WEINGARTEN, GG
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (10) : 1657 - 1665
  • [29] SUBUNIT SPECIFICITY OF MUTATIONS THAT CONFER RESISTANCE TO NONNUCLEOSIDE INHIBITORS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    BOYER, PL
    DING, JP
    ARNOLD, E
    HUGHES, SH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) : 1909 - 1914
  • [30] THE PETT SERIES, A NEW CLASS OF POTENT NONNUCLEOSIDE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    AHGREN, C
    BACKRO, K
    BELL, FW
    CANTRELL, AS
    CLEMENS, M
    COLACINO, JM
    DEETER, JB
    ENGELHARDT, JA
    HOGBERG, M
    JASKUNAS, SR
    JOHANSSON, NG
    JORDAN, CL
    KASHER, JS
    KINNICK, MD
    LIND, P
    LOPEZ, C
    MORIN, JM
    MUESING, MA
    NOREEN, R
    OBERG, B
    PAGET, CJ
    PALKOWITZ, JA
    PARRISH, CA
    PRANC, P
    RIPPY, MK
    RYDERGARD, C
    SAHLBERG, C
    SWANSON, S
    TERNANSKY, RJ
    UNGE, T
    VASILEFF, RT
    VRANG, L
    WEST, SJ
    ZHANG, H
    XHOU, XX
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) : 1329 - 1335
12345